en
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
 cn

Process Impurity Analysis

Capable of utilizing both analytical and bio-analytical tools to address residual chemical, formulation components stability, bacterial/virus, or protein-related compounds for safety concerns, with rational selection of reliable assays under regulatory guideline as going forward.

Related CRO & CDMO Services

Bioavailability Enhancement Formulations Bioavailability Enhancement Formulations
Oral Solid Dosage Forms Oral Solid Dosage Forms
Clinical and Commercial Manufacturing Clinical and Commercial Manufacturing

Related Updates in Crystal Pharmatech

Characterization and Evaluation of Amorphous Solid Dispersion (ASD) - Part 1
Characterization and Evaluation of Amorphous Solid Dispersion (ASD) - Part 1
30 Apr 2024
Unveil Key Factors Influencing the Physical Stability of Amorphous Solid Dispersions
Unveil Key Factors Influencing the Physical Stability of Amorphous Solid Dispersions
13 Mar 2024
Review of Polymorph Patent Application of 30 Small Molecule New Drugs Approved by the FDA in 2023
Review of Polymorph Patent Application of 30 Small Molecule New Drugs Approved by the FDA in 2023
26 Feb 2024
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Technology
Quick Links
About Us Events
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Sitemap
Privacy Policy
API Form and Solid-State Research
Solid Form Screening and Selection Single Crystal Growth & Structure Determination Solid-State NMR Analysis
Analytical Chemistry
Pre-formulation Studies
Formulation Development
Clinical and Commercial Manufacturing
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Formulation Development for Poorly Water-Soluble Drugs Mini-Tablet
Quick Links
About Us Technical Articles Events
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303
Sitemap
Privacy Policy